Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1980 1
1981 2
1982 1
1983 2
1984 2
1988 3
1990 1
1991 2
1992 4
1993 2
1994 5
1995 3
1996 1
1997 4
1998 2
1999 2
2000 2
2001 4
2002 5
2003 2
2004 4
2005 4
2006 4
2007 9
2008 7
2009 8
2010 7
2011 8
2012 7
2013 5
2014 6
2015 9
2016 8
2017 3
2018 6
2019 5
2020 7
2021 9
2022 6
2023 6
2024 7
2025 4

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

171 results

Results by year

Filters applied: . Clear all
Page 1
Trifluridine-Tipiracil and Bevacizumab in Refractory Metastatic Colorectal Cancer.
Prager GW, Taieb J, Fakih M, Ciardiello F, Van Cutsem E, Elez E, Cruz FM, Wyrwicz L, Stroyakovskiy D, Pápai Z, Poureau PG, Liposits G, Cremolini C, Bondarenko I, Modest DP, Benhadji KA, Amellal N, Leger C, Vidot L, Tabernero J; SUNLIGHT Investigators. Prager GW, et al. N Engl J Med. 2023 May 4;388(18):1657-1667. doi: 10.1056/NEJMoa2214963. N Engl J Med. 2023. PMID: 37133585 Clinical Trial.
Lanreotide in metastatic enteropancreatic neuroendocrine tumors.
Caplin ME, Pavel M, Ćwikła JB, Phan AT, Raderer M, Sedláčková E, Cadiot G, Wolin EM, Capdevila J, Wall L, Rindi G, Langley A, Martinez S, Blumberg J, Ruszniewski P; CLARINET Investigators. Caplin ME, et al. N Engl J Med. 2014 Jul 17;371(3):224-33. doi: 10.1056/NEJMoa1316158. N Engl J Med. 2014. PMID: 25014687 Free article. Clinical Trial.
Position paper on olfactory dysfunction.
Hummel T, Whitcroft KL, Andrews P, Altundag A, Cinghi C, Costanzo RM, Damm M, Frasnelli J, Gudziol H, Gupta N, Haehne A, Holbrook E, Hong SC, Hornung D, Hüttenbrink KB, Kamel R, Kobayashi M, Konstantinidis I, Landis BN, Leopold DA, Macchi A, Miwa T, Moesges R, Mullol J, Mueller CA, Ottaviano G, Passali GC, Philpott C, Pinto JM, Ramakrishnan VJ, Rombaux P, Roth Y, Schlosser RA, Shu B, Soler G, Stjärne P, Stuck BA, Vodicka J, Welge-Luessen A. Hummel T, et al. Among authors: soler g. Rhinol Suppl. 2017 Mar;54(26):1-30. doi: 10.4193/Rhino16.248. Rhinol Suppl. 2017. PMID: 29528615 Review.
Deciphering HER2-low breast cancer (BC): insights from real-world data in early stage breast cancer.
Pous A, Bernat-Peguera A, López-Paradís A, Cirauqui B, Quiroga V, Teruel I, Felip E, Ferrando-Díez A, Bergamino M, Boronat L, Romeo M, Soler G, Mariño C, Rodríguez-Martínez P, Pons L, Ballana E, Martinez-Cardús A, Margelí M. Pous A, et al. Among authors: soler g. Ther Adv Med Oncol. 2024 Oct 23;16:17588359241290720. doi: 10.1177/17588359241290720. eCollection 2024. Ther Adv Med Oncol. 2024. PMID: 39449733 Free PMC article.
Molecular landscape of mature B-cell lymphoproliferative disorders with BCL3-translocation: A Groupe Francophone de Cytogénétique Hématologique (GFCH)/French Innovative Leukemia Organization (FILO) study.
Véronèse L, Bensaber H, Dannus LT, Giannone G, Choiset C, Grimpret C, Abermil N, Balducci E, Bidet A, Chapiro E, Couronné L, Daudignon A, Douet-Gilbert N, Eclache V, Gaillard B, Gaillard JB, Hsoumi F, Lefebvre C, Nadal N, Mozziconacci MJ, Penther D, Ribourtout B, Richebourg S, Rigollet L, Terre C, Soler G, Tournilhac O, Guièze R, Nguyen-Khac F, Tchirkov A. Véronèse L, et al. Among authors: soler g. Am J Hematol. 2024 Sep;99(9):1830-1833. doi: 10.1002/ajh.27384. Epub 2024 May 30. Am J Hematol. 2024. PMID: 38817040 Free article. No abstract available.
Global tracking of marine megafauna space use reveals how to achieve conservation targets.
Sequeira AMM, Rodríguez JP, Marley SA, Calich HJ, van der Mheen M, VanCompernolle M, Arrowsmith LM, Peel LR, Queiroz N, Vedor M, da Costa I, Mucientes G, Couto A, Humphries NE, Abalo-Morla S, Abascal FJ, Abercrombie DL, Abrantes K, Abreu-Grobois FA, Afonso AS, Afonso P, Ahonen H, Åkesson S, Alfaro-Shigueto J, Andrews RD, Angelier F, Antonopoulou M, Arata JA, Araujo G, Arauz R, Arcos JM, Arregui I, Arrizabalaga H, Auger-Méthé M, Bach S, Bailleul F, Baird RW, Balazs GH, Barco SG, Barnett A, Baverstock W, Baylis AMM, Beard A, Bécares J, Belda EJ, Bell I, Bennison A, Benson SR, Bernal D, Berumen ML, Bessudo S, Bezerra NPA, Blaison AV, Blanco GS, Block BA, Bolton M, Bond ME, Bonfil R, Braun CD, Broderick AC, Brooke ML, Brooks AML, Brooks EJ, Bruno IM, Burns JM, Byrne ME, Campana SE, Campbell HA, Campbell RA, Carlisle A, Carmichael RH, Carroll G, Casale P, Ceia FR, Chapman DD, Chapple TK, Charrassin JB, Chiaradia A, Chisholm J, Clarke CR, Clay TA, Cleguer C, Clingham E, Clua EEG, Cochran JEM, Constantine R, Cooper RW, Crochelet E, Cronin M, Cuevas E, DaCosta KP, Dagorn L, Daly R, Davis RW, de Bruyn PJN, Delgado-Trejo C, Dellinger T, Derville S, Diamant S, DiMatteo A, Dodge KL, Doherty P… See abstract for full author list ➔ Sequeira AMM, et al. Among authors: soler ga. Science. 2025 Jun 5;388(6751):1086-1097. doi: 10.1126/science.adl0239. Epub 2025 Jun 5. Science. 2025. PMID: 40472106
Impact of Treatment With Trifluridine/Tipiracil in Combination With Bevacizumab on Health-Related Quality of Life and Performance Status in Refractory Metastatic Colorectal Cancer: An Analysis of the Phase III SUNLIGHT Trial.
Taieb J, Fakih M, Tabernero J, Ciardiello F, Van Cutsem E, Soler G, Calleja E, Barboux V, Roby L, Amellal N, Prager GW. Taieb J, et al. Among authors: soler g. Clin Colorectal Cancer. 2025 Jun;24(2):180-187.e4. doi: 10.1016/j.clcc.2024.12.002. Epub 2024 Dec 11. Clin Colorectal Cancer. 2025. PMID: 39818468 Free article. Clinical Trial.
Changes In Serum CXCL13 Levels Are Associated With Outcomes of Colorectal Cancer Patients Undergoing First-Line Oxaliplatin-Based Treatment.
Cabrero-de Las Heras S, Hernández-Yagüe X, González A, Losa F, Soler G, Bugés C, Baraibar I, Esteve A, Pardo-Cea MÁ, Ree AH, Martínez-Bosch N, Nieva M, Musulén E, Meltzer S, Lobato T, Vendrell-Ayats C, Queralt C, Navarro P, Montagut C, Grau-Leal F, Camacho D, Legido R, Mulet-Margalef N, Martínez-Balibrea E. Cabrero-de Las Heras S, et al. Among authors: soler g. Biomed Pharmacother. 2024 Jul;176:116857. doi: 10.1016/j.biopha.2024.116857. Epub 2024 Jun 7. Biomed Pharmacother. 2024. PMID: 38850664 Free article.
171 results